The present invention relates to novel quinoline derivatives such as compounds of the formula (I) which have antagonist potency for the 5-HT6 receptor and the use of such compounds or pharmaceutical compositions thereof in the treatment of CNS and other disorders.
本发明涉及新型
喹啉衍
生物,如式(I)化合物,其具有对5-HT6受体的拮抗作用,以及这些化合物或其药物组合物在治疗中枢神经系统和其他疾病中的用途。